BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 3486924)

  • 1. Induction of interleukin-1 by strains of Staphylococcus aureus from patients with nonmenstrual toxic shock syndrome.
    Parsonnet J; Gillis ZA; Pier GB
    J Infect Dis; 1986 Jul; 154(1):55-63. PubMed ID: 3486924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
    Bonventre PF; Weckbach L; Harth G; Haidaris C
    Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxin involvement in toxic shock syndrome.
    Crass BA; Bergdoll MS
    J Infect Dis; 1986 May; 153(5):918-26. PubMed ID: 3701106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
    Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay.
    Rosten PM; Bartlett KH; Chow AW
    J Clin Microbiol; 1987 Feb; 25(2):327-32. PubMed ID: 3818927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of staphylococcal enterotoxins in nonmenstrual toxic shock syndrome.
    Crass BA; Bergdoll MS
    J Clin Microbiol; 1986 Jun; 23(6):1138-9. PubMed ID: 3711305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins.
    Garbe PL; Arko RJ; Reingold AL; Graves LM; Hayes PS; Hightower AW; Chandler FW; Broome CV
    JAMA; 1985 May; 253(17):2538-42. PubMed ID: 3981783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of developing toxic shock syndrome associated with toxic shock syndrome toxin 1 following nongenital staphylococcal infection.
    Jacobson JA; Kasworm E; Daly JA
    Rev Infect Dis; 1989; 11 Suppl 1():S8-13. PubMed ID: 2928655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus.
    Lee JC; Liu MJ; Parsonnet J; Arbeit RD
    J Clin Microbiol; 1990 Dec; 28(12):2612-5. PubMed ID: 2279990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.
    Bergdoll MS; Crass BA; Reiser RF; Robbins RN; Davis JP
    Lancet; 1981 May; 1(8228):1017-21. PubMed ID: 6112412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low incidence of toxic shock syndrome in children with staphylococcal infection.
    Jacobson JA; Kasworm EM; Reiser RF; Bergdoll MS
    Am J Med Sci; 1987 Dec; 294(6):403-7. PubMed ID: 3425588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of human interleukin-1 by toxic-shock-syndrome toxin-1.
    Parsonnet J; Hickman RK; Eardley DD; Pier GB
    J Infect Dis; 1985 Mar; 151(3):514-22. PubMed ID: 3871826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.
    Bohach GA; Fast DJ; Nelson RD; Schlievert PM
    Crit Rev Microbiol; 1990; 17(4):251-72. PubMed ID: 2206394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation in Staphylococcus aureus infections between toxic shock syndrome toxin-1 production and clinical feature].
    Kiyota H; Ohishi Y; Onodera S; Miki K; Ueda M
    Kansenshogaku Zasshi; 1998 Jun; 72(6):593-8. PubMed ID: 9695469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to toxic-shock-syndrome toxin-1 (TSST-1) and to staphylococcal enterotoxins A, B and C in Staphylococcus aureus infections.
    Kunstmann G; Schröder E; Hasbach H; Pulverer G
    Zentralbl Bakteriol; 1989 Oct; 271(4):486-92. PubMed ID: 2818798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterotoxins and toxic-shock syndrome toxin-1 in non-enteric staphylococcal disease.
    Marples RR; Wieneke AA
    Epidemiol Infect; 1993 Jun; 110(3):477-88. PubMed ID: 8519313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination by western blot (immunoblot) of seroconversions to toxic shock syndrome (TSS) toxin 1 and enterotoxin A, B, or C during infection with TSS- and non-TSS-associated Staphylococcus aureus.
    Whiting JL; Rosten PM; Chow AW
    Infect Immun; 1989 Jan; 57(1):231-4. PubMed ID: 2909490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates.
    Lee VT; Chang AH; Chow AW
    J Infect Dis; 1992 Oct; 166(4):911-5. PubMed ID: 1527429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of toxic shock syndrome isolates producing staphylococcal enterotoxins B and C1 with use of southern hybridization and immunologic assays.
    Bohach GA; Kreiswirth BN; Novick RP; Schlievert PM
    Rev Infect Dis; 1989; 11 Suppl 1():S75-81; discussion S81-2. PubMed ID: 2494691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial laryngotracheitis associated with toxic shock syndrome in an adult.
    Dann EJ; Weinberger M; Gillis S; Parsonnet J; Shapiro M; Moses AE
    Clin Infect Dis; 1994 Mar; 18(3):437-9. PubMed ID: 8011830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.